A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

Rethinking schizophrenia

Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484

The NIMH-MATRICS Consensus Statement on Negative Symptoms

Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311

Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria

Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., Frese, F., Goldberg, T. E., Heaton, R. K., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.023 · Cited by 919

Trace amines: Identification of a family of mammalian G protein-coupled receptors

Borowsky, B., Adham, N., Jones, K. A., Raddatz, R., Artymyshyn, R., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 906

Catching Up on Schizophrenia

Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 811

Anatomical Profiling of G Protein-Coupled Receptor Expression

Regard, J. B., Sato, I. T., & Coughlin, S. R. (2008) · Cell · doi:10.1016/j.cell.2008.08.040 · Cited by 693

Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence

Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. L. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.237 · Cited by 688

Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor

Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 648

In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice

Cryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616

Antipsychotic-induced weight gain: a review of the literature.

Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 595

Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder

Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1018 · Cited by 538

Schizophrenia

Carpenter, W. T., & Buchanan, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403103301006 · Cited by 510

Effect of ethanol on liver 8-aminolaevulinate synthetase in rats.

SHANLEY, B. C., Zail, S. S., & Joubert, S. M. (1968) · The Lancet · Cited by 428

Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine

Jentsch, J. D., Redmond, D. E., Elsworth, J. D., Taylor, J. R., Youngren, K. D., & Roth, R. H. (1997) · Science · doi:10.1126/science.277.5328.953 · Cited by 398

The catalepsy test: Its ups and downs.

Sanberg, P. R., Bunsey, M. D., Giòrdano, M., & Norman, A. B. (1988) · Behavioral Neuroscience · doi:10.1037//0735-7044.102.5.748 · Cited by 375

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Revel, F. G., Moreau, J.-L., Gainetdinov, R. R., Bradaia, A., Sotnikova, T. D., Mory, R., Durkin, S., Zbinden, K. G., Norcross, R., Meyer, C. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103029108 · Cited by 364

Our Reviewers: (Editorial)

Gelenberg, A. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0101 · Cited by 356

Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaia, A., Ozmen, L., Bluethmann, H., Bettler, B., Wettstein, J. G., Borroni, E., Moreau, J.-L., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132647 · Cited by 348

Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.

Robertson, G. S., Matsumura, H., & Fibiger, H. C. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23800-9 · Cited by 309

Neurobiological mechanisms for the regulation of mammalian sleep–wake behavior: Reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence

Datta, S., & MacLean, R. R. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.02.004 · Cited by 296

A renaissance in trace amines inspired by a novel GPCR family

Lindemann, L., & Hoener, M. C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.007 · Cited by 287

Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors

Lindemann, L., Ebeling, M., Kratochwil, N. A., Bunzow, J. R., Grandy, D. K., & Hoener, M. C. (2005) · Genomics · doi:10.1016/j.ygeno.2004.11.010 · Cited by 278

Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia

Abi-Dargham, A., & Moore, H. (2003) · The Neuroscientist · doi:10.1177/1073858403252674 · Cited by 277

The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

Bradaia, A., Trube, G., Stalder, H., Norcross, R. D., Ozmen, L., Wettstein, J. G., Pinard, A., Buchy, D., Gassmann, M., Hoener, M. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906522106 · Cited by 250

The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity: TAAR1 regulation of monoaminergic activity

Miller, G. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07109.x · Cited by 249

The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia

Wolinsky, T. D., Swanson, C. J., Smith, K. E., Zhong, H., Borowsky, B., Seeman, P., Branchek, T., & Gerald, C. P. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00292.x · Cited by 245

The Impact of Weight Gain on Quality of Life Among Persons With Schizophrenia

Allison, D. B., Mackell, J. A., & McDonnell, D. D. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.4.565 · Cited by 245

Probing cell type–specific functions of Gi in vivo identifies GPCR regulators of insulin secretion

Regard, J. B., Kataoka, H., Cano, D. A., Camerer, E., Yin, L., Zheng, Y.-W., Scanlan, T. S., Hebrok, M., & Coughlin, S. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32994 · Cited by 233

Phenylethylamine in Paranoid Chronic Schizophrenia

Potkin, S. G., Karoum, F., Chuang, L.-W., Cannon-Spoor, H. E., Phillips, I., & Wyatt, R. J. (1979) · Science · doi:10.1126/science.504988 · Cited by 224

The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain

Burchett, S. A., & Hicks, T. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.003 · Cited by 217

The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities

Carpenter, W. T., & Koenig, J. I. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 206

Genetic animal models: focus on schizophrenia

Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01886-5 · Cited by 201

PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in rats

Rodefer, J. S., Murphy, E. R., & Baxter, M. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03937.x · Cited by 199

Trace amine-associated receptor 1—Family archetype or iconoclast?

Grandy, D. K. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.007 · Cited by 197

Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor

Espinoza, S., Salahpour, A., Masri, B., Sotnikova, T. D., Messa, M., Barak, L. S., Caron, M. G., & Gainetdinov, R. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073304 · Cited by 197

Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies

Abi-Dargham, A., & Laruelle, M. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.11.003 · Cited by 179

The pharmacology of weight gain with antipsychotics.

Casey, D. E., & Zorn, S. H. (2001) · PubMed · Cited by 164

RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

Ballard, T. M., Knoflach, F., Prinssen, E. P. M., Borroni, E., Vivian, J. A., Basile, J., Gasser, R., Moreau, J., Wettstein, J. G., Buettelmann, B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1357-7 · Cited by 158

The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases

Berry, M. D. (2007) · Reviews on Recent Clinical Trials · doi:10.2174/157488707779318107 · Cited by 135

Aromaticl-amino acid decarboxylase: A neglected and misunderstood enzyme

Berry, M. D., Juorio, A. V., Li, X.-M., & Boulton, A. A. (1996) · Neurochemical Research · doi:10.1007/bf02532418 · Cited by 132

DOES PHENYLETHYLAMINE CAUSE SCHIZOPHRENIA?

Sandler, M., & Reynolds, G. P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90156-2 · Cited by 130

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics

Rodefer, J. S., Nguyen, T. N., Karlsson, J.-J., & Arnt, J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301654 · Cited by 126

Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques

Rutten, K., Basile, J., Prickaerts, J., Blokland, A., & Vivian, J. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0999-1 · Cited by 125

Tardive dyskinesia and atypical antipsychotic drugs

CASEY, D. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00160-1 · Cited by 121

Selective 5HT2A and 5HT6 Receptor Antagonists Promote Sleep in Rats

Morairty, S. R., Hedley, L. R., Flores, J., Martin, R. S., & Kilduff, T. S. (2008) · SLEEP · doi:10.1093/sleep/31.1.34 · Cited by 118

RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

Wallace, T. L., Callahan, P. M., Tehim, A., Bertrand, D., Tombaugh, G. C., Wang, S., Xie, W., Rowe, W. B., Ong, V., Graham, E., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171892 · Cited by 115

Dissociation of Haloperidol, Clozapine, and Olanzapine Effects on Electrical Activity of Mesocortical Dopamine Neurons and Dopamine Release in the Prefrontal Cortex

Gessa, G. L. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00087-7 · Cited by 110

Preclinical models of antipsychotic drug-induced metabolic side effects

Boyda, H. N., Tse, L., Procyshyn, R. M., Honer, W. G., & Barr, A. M. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.07.002 · Cited by 109

8-OH-DPAT, a 5-HT 1A agonist and ritanserin, a 5-HT 2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

Lucas, G., Bonhomme, N., Deurwaerdère, P. D., Moal, M. L., & Spampinato, U. (1997) · Psychopharmacology · doi:10.1007/s002130050265 · Cited by 105

Drug Induced Weight Gain, an Impediment to Successful Pharmacotherapy: Focus on Antipsychotics

Baptista, T., Zarate, J. M., Joober, R., Colasante, C., Beaulieu, S., Páez, X., & Hernandez, L. (2004) · Current Drug Targets · doi:10.2174/1389450043490514 · Cited by 99

Trace Amine-Associated Receptors as Emerging Therapeutic Targets

Sotnikova, T. D., Caron, M. G., & Gainetdinov, R. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055970 · Cited by 97

Anatomical and histological profiling of orphan G-protein-coupled receptor expression in gastrointestinal tract of C57BL/6J mice

Itô, J., Ito, M., Nambu, H., Fujikawa, T., Tanaka, K., Iwaasa, H., & Tokita, S. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0859-x · Cited by 96

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

Large, C. H. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077712 · Cited by 95

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits

Jentsch, J. D., Taylor, J. R., Elsworth, J. D., Redmond, D. E., & Roth, R. H. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00481-3 · Cited by 91

HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes

D’Andrea, G., Terrazzino, S., Fortin, D., Farruggio, A., Rinaldi, L., & Leon, A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00573-1 · Cited by 87

Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule

O’Donnell, J. M., Marek, G. J., & Seiden, L. S. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.018 · Cited by 84

Expression of Neuronal Trace Amine-associated Receptor (Taar) mRNAs in Leukocytes

Nelson, D. A., Tolbert, M. D., Singh, S. J., & Bost, K. L. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.08.006 · Cited by 79

Phenylethylamine modulation of affect: therapeutic and diagnostic implications

SABELLI, H. C., & Javaid, J. I. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.1.6 · Cited by 78

Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats

Nordquist, R. E., Risterucci, C., Moreau, J., von Kienlin, M., Künnecke, B., Maco, M., Freichel, C., Riemer, C., & Spooren, W. P. J. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.010 · Cited by 68

Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773)

Stalder, H., Hoener, M. C., & Norcross, R. D. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.075 · Cited by 63

Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects

Davis, B. A. (1989) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)84617-3 · Cited by 61

Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats

Bruns, A., Künnecke, B., Risterucci, C., Moreau, J., & von Kienlin, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21779 · Cited by 60

Quantitative Body Composition Analysis in Awake Mice and Rats by Magnetic Resonance Relaxometry

Künnecke, B., Verry, P., Benardeau, A. M., & von Kienlin, M. (2004) · Obesity Research · doi:10.1038/oby.2004.200 · Cited by 59

Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia

Risterucci, C., Jeanneau, K., Schöppenthau, S., Bielser, T., Künnecke, B., von Kienlin, M., & Moreau, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2204-8 · Cited by 56

Trace amines and their relevance to psychiatry and neurology: a brief overview

Narang, D., Tomlinson, S. E., Holt, A., Mousseau, D. D., & Baker, G. B. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20110403020951 · Cited by 29

Better pharmacotherapy for schizophrenia: What does the future hold?

Webber, M. A., & Marder, S. R. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0056-8 · Cited by 28

Modulation of stress by imidazoline binding sites: Implications for psychiatric disorders

Smith, K. L., Jessop, D. S., & Finn, D. P. (2008) · Stress · doi:10.1080/10253890802302908 · Cited by 26

Behavioral effects of clozapine: Involvement of trace amine pathways in C. elegans and M. musculus

Karmacharya, R., Lynn, S. K., DeMarco, S., Ortiz, A., Wang, X., Lundy, M. Y., Xie, Z., Cohen, B. M., Miller, G. M., & Buttner, E. A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.010 · Cited by 26

Antipsychotic Drug Development

Kim, D. H., & Stahl, S. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_47 · Cited by 25

Trace amines and their relevance to psychiatry and neurology: a brief overview / Eser aminler ve psikiyatri ve nöroloji ile ilişkisi: Kısa bir gözden geçirme

Narang, D., Tomlinson, S. E., Holt, A., Mousseau, D. D., & Baker, G. B. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5350/kpb-bcp201121113 · Cited by 23

Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential

Alberati, D., Moreau, J., Mory, R., Pinard, E., & Wettstein, J. G. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.07.016 · Cited by 18

Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.

Jl, S., Coffey, C. E., Basuk, B., Jo, C., Maltbie, A. A., & Ww, Z. (1980) · PubMed · Cited by 17

Molecular Brain Imaging and the Neurobiology and Genetics of Schizophrenia

Heinz, A., Romero, B., Gallinat, J., Juckel, G., & Weinberger, D. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45123 · Cited by 1

Dopamine receptors –IUPHAR R eview 13

Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 521

Trace Amines and Their Receptors

Gainetdinov, R. R., Hoener, M. C., & Berry, M. D. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015305 · Cited by 384

The Case for TAAR1 as a Modulator of Central Nervous System Function

Rutigliano, G., Accorroni, A., & Zucchi, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00987 · Cited by 166

The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors

De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.022 · Cited by 110

Electroacupuncture alleviated depression‐like behaviors in ventromedial prefrontal cortex of chronic unpredictable mild stress‐induced rats: Increasing synaptic transmission and phosphorylating dopamine transporter

Cai, X., Wu, M., Zhang, Z., Liu, H., Huang, S., Song, J., Ren, S., & Huang, Y. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14200 · Cited by 28